Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$12.08 - $18.56 $275,158 - $422,759
-22,778 Reduced 11.03%
183,766 $3.09 Million
Q4 2023

Feb 12, 2024

BUY
$16.25 - $20.23 $2.99 Million - $3.72 Million
184,123 Added 821.21%
206,544 $3.74 Million
Q3 2023

Nov 13, 2023

BUY
$11.85 - $16.95 $265,688 - $380,035
22,421 New
22,421 $379,000
Q3 2022

Nov 14, 2022

SELL
$8.63 - $15.52 $23,551 - $42,354
-2,729 Reduced 2.54%
104,504 $926,000
Q2 2022

Aug 11, 2022

BUY
$8.59 - $20.77 $101,928 - $246,456
11,866 Added 12.44%
107,233 $1.36 Million
Q1 2022

May 16, 2022

BUY
$15.52 - $35.65 $372,976 - $856,740
24,032 Added 33.69%
95,367 $1.81 Million
Q4 2021

Feb 11, 2022

SELL
$28.89 - $35.33 $133,847 - $163,683
-4,633 Reduced 6.1%
71,335 $2.5 Million
Q3 2021

Nov 12, 2021

BUY
$35.66 - $42.94 $582,613 - $701,553
16,338 Added 27.4%
75,968 $2.78 Million
Q2 2021

Aug 13, 2021

BUY
$23.7 - $39.27 $33,061 - $54,781
1,395 Added 2.4%
59,630 $2.34 Million
Q1 2021

May 14, 2021

BUY
$27.01 - $36.8 $24,309 - $33,120
900 Added 1.57%
58,235 $1.65 Million
Q4 2020

Feb 12, 2021

BUY
$27.51 - $34.36 $125,418 - $156,647
4,559 Added 8.64%
57,335 $1.84 Million
Q3 2020

Nov 12, 2020

BUY
$25.8 - $34.61 $824,671 - $1.11 Million
31,964 Added 153.58%
52,776 $1.71 Million
Q2 2020

Aug 14, 2020

SELL
$17.65 - $28.05 $718,019 - $1.14 Million
-40,681 Reduced 66.16%
20,812 $574,000
Q1 2020

May 15, 2020

SELL
$15.19 - $29.51 $526,667 - $1.02 Million
-34,672 Reduced 36.05%
61,493 $1.1 Million
Q4 2019

Feb 14, 2020

BUY
$17.17 - $25.95 $204,168 - $308,571
11,891 Added 14.11%
96,165 $2.41 Million
Q3 2019

Nov 14, 2019

BUY
$17.84 - $22.69 $32,433 - $41,250
1,818 Added 2.2%
84,274 $1.5 Million
Q2 2019

Aug 13, 2019

BUY
$22.0 - $31.78 $327,206 - $472,663
14,873 Added 22.01%
82,456 $1.81 Million
Q1 2019

May 15, 2019

BUY
$21.27 - $30.58 $1.11 Million - $1.6 Million
52,159 Added 338.17%
67,583 $2.07 Million
Q4 2018

Feb 13, 2019

BUY
$23.09 - $37.69 $356,140 - $581,330
15,424 New
15,424 $356,000
Q1 2018

May 11, 2018

SELL
$28.87 - $41.13 $1.87 Million - $2.66 Million
-64,753 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$27.41 - $39.42 $1.77 Million - $2.55 Million
64,753
64,753 $2.55 Million

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $2.47B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.